Time-resolved fluorescence in immunocytochemical detection of prostate-specific antigen in prostatic tissue sections

Histochemical Journal

Volumn 31, Issue 1, 1999, Pages 45-52

  Bjartell, Anders ^a   Laine, Sari ^b   Pettersson, Kim ^b   Nilsson, Elise ^a   Lövgren, Timo ^b   Lilja, Hans ^a  

^a LUND UNIVERSITY   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; CHELATE; EUROPIUM; HORSERADISH PEROXIDASE; LANTHANIDE; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; STREPTAVIDIN; TERBIUM;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; AUTOFLUORESCENCE; BLADDER CANCER; CLINICAL ARTICLE; FLUORESCENCE HISTOCHEMISTRY; FLUOROIMMUNOASSAY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; REACTION TIME;

AGED; AGED, 80 AND OVER; EUROPIUM; FLUORESCENCE; FLUOROIMMUNOASSAY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MICROTOMY; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; STREPTAVIDIN;

ARMORACIA RUSTICANA; EQUUS CABALLUS; RAPHANUS SATIVUS;

EID: 0032980411     PISSN: 00182214     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1003504115690     Document Type: Article

References (34)

1. Abrahamsson P-A, Lilja H, Falkmer S, Wildström LB (1988) Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. The Prostate 12: 39-46.
2. Ahiyama K, Nakamura T, Iwamura S, Hara M (1987) The chymotrypsin-like activity of the prostate-specific antigen, g-semino protein. FEBS Lett 225: 168-172.
3. Beverloo HB, Van Schadewijk A, Van Gelderen Boele S, Tanke HJ (1990) Inorganic phosphors as new luminescent labels for immunocytochemistry and time-resolved microscopy. Cytometry 11: 784-792.
4. Beverloo HB, Van Schadewijk A, Zijlmans HJ, Verwoerd NP, Bonnett J, Vrolijk H, Tanke HJ (1993) A comparison of the detection sensitivity of lymphocyte membrane antigens using fluorescein and phosphor immunoconjugates. J Histochem Cytochem 41: 719-725.
5. Bjartell A, Björk T, Matikainen M-T, Abrahamsson P-A, Di Santágnese A, Lilja H (1993) Production of alpha-1-antichymotrypsin by PSA-containing cells of human prostate epithelium. Urology 42: 502-510.
6. Björk T, Bjartell A, Abrahamsson P-A, Hulkko S, Di Santágnese A, Lilja H (1994). Alpha-1-antichymotrypsin production in PSA-containing cells is common in prostate cancer but rare in benign prostatic hyperplasia. Urology 3: 427-434.
7. Brawer MK, Lange PH (1989) Prostate-specific antigen in management of prostatic carcinoma. Urology (Suppl 5) 33: 11-16.
8. Brawer MK (1991) Prostate specific antigen. Acta Onkologica 30: 161-168.
9. Catalona W, Smith D, Batliff TL, Dodds KM, Coplen DE, Yuan JJJ, Petros JA and Andriole GL (1991) Measurements of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324: 1156-1161.
10. Clements JA (1994) The human kallikrein family: a diversity of expression and function. Mol Cell Endocrinol 99: C1-C6.
11. de Haas RR, Verwoerd NP, Van Der Corput MP, Van Gijlswijk RP, Siitari-H, Tanke HJ (1996) The use of peroxidase-mediated deposition of biotin-tyramide in combination with time-resolved fluorescence imaging of europium chelate label in immunohistochemistry and in situ hybridization. J Histochem Cytochem 44: 1091-1099.
12. Fazekas De St Groth S, Scheidegger D (1980) Production of Monoclonal Antibodies: Strategy and Tactics. J Immunol Methods 35: 1-21.
13. Frazier HA, Humphrey PA, Burchette JL, Paulson DF (1992) Immunoreactive prostate-specific antigen in male peri-urethral glands. J Urol 147: 246-248.
14. Hemmilä I, Dakabu S, Mukkala V-M, Siitari H, Lo7die;vgren T (1984) Europium as label in time-resolved immunuflouorometric assays. Analyt Biochem 137: 335-343.
15. Hemmitä IA (1991) Applications of fluorescence in immunoassays. New York, John Wiley & Sons.
16. Hsu S, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in Immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580.
17. Lilja H (1985) A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 76: 1899-1903.
18. Lilja H, Abrahamsson P-A (1988) Three predominant proteins secreted from the human prostate gland. Prostate 12: 29-38.
19. Lilja H, Christensson A, Dahlén U, Matikainen M-T, Nilsson O, Pettersson K Lövgren T (1991) Prostate-specific antigen in human serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin chem 37: 1618-1625.
20. Lövgren T, Hemmiläi, Pettersson K, Halonen P (1985) Time-resolved flurometry in immunoassays. In (Collins W. ed.) Alternative Immunoassays, John Wiley & Sons Ltd. Chichester, UK, pp. 203-217 (Review).
21. Mukkala V-M, Helenius M, Hemmilä I, Kankare J, Takalo H (1993) Development of luminescent europium (III) and terbium (III) chelates of 2,2: 6, 2-terpyridine derivatives for protein labeling. Helvetica Chimica Acta 76: 1361-1378.
22. Oesterling JE (1991) Prostate specific antigen: A critical assessment on the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907-923.
23. Papsidero LD, Wang MC, Valenzuela LA, Murphy GP, Chu TM (1980) A prostate antigen in sera of prostalic cancer patients. Cancer Res 40: 2428-2432.
24. Pettersson K, Piironen T, Seppälä M, Liukkonen L, Christensson A, Matikainen M-T, Suonpää M, Lövgren T, Lilja H (1995) Free and complexed Prostate-specific antigen (PSA): In vitro stability, epitope map, and development of immunofluoreometric assays for specific and sensitive detection of free PSA and PSA-alpha-1-antichymotrypsin complex. Clin Chem 41: 1480-1488.
25. Seveus L, Väisälä M, Syrjänen S, Sandberg M, Kuusisto A, Harjo R, Salo J, Hemmilä I, Kojola M, Soini E (1992) Time-resolved fluorescence imaging of europium chelate label in immunohistochemistry and in situ hybridization. Cytometry 13: 329-338.
26. Shi Z-R, Itzkowitz SH, Kim YS (1988) A comparison of three Immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. J Histochem Cytochem 36: 317-322.
27. Soini EJ, Lövgren T (1987) Time-resolved fluorescence of lanthanide probes and applications in biotechnology. CRC Crit Rev Anal Chem 18: 105-154.
28. Soini EJ, Pelliniemi LJ, Hemmilä IA, Mukkala V-M, Kankare JJ, Fröjdman K (1988) Lanthanide chelates as new fluorochrome labels for cytochemistry. J Histochem Cytochem 36: 1449-1451.
29. Stamey TA, Yang N, Hay AR, McNeil JE, Freika FS, Redwine E (1987) Prostate-specific antigen as a marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916.
30. Takalo H, Mukkala V-M, Mikola H, Liitti P, Hemmilä I (1994) Synthesis of europium (III) chelates suitable for labeling of bioactive molecules. Bioconjugate Chem 5: 278-282.
31. Takalo H, Hänninen E, Kankare J (1993) Luminescence of europium (III) chelates of substituted 4-phenylethynylpyridines as ligands. Helv Chim Aseta 76: 877-883.
32. Wang MC, Valenzuela CA, Murphy GP, Chu TM (1979) Purification of a human prostate-specific antigen. Invest Urol 17: 159-163.
33. van Gijlswijk RP, Zijlmans HJ, Wiegant J, Bobrow MN, Erickson TJ, Adler KE, Tanke HJ, Raap AK (1997) Fluorochrome-labeled lyramides: use in immunocytochemistry and fluorescence in situ hybridization. J Histochem Cytochem 45: 375-382.
34. Verwoerd NP, Hennink EJ, Bonnet J, Van Der Geest CR, Tanke HJ (1994) Use of ferro-electric liquid crystal shutters for time-resolved fluorescence microscopy. Cytometry 16: 113-117.